ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,193,202 | +93.1% | 68,923 | +1.6% | 0.05% | +80.0% |
| Q1 2019 | $1,653,500 | +69.5% | 67,822 | -0.9% | 0.03% | +50.0% |
| Q4 2018 | $975,498 | -5.3% | 68,456 | +1.0% | 0.02% | +11.1% |
| Q3 2018 | $1,030,134 | -99.9% | 67,772 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $1,137,214,000 | -45.7% | 67,772 | -47.2% | 0.02% | -40.0% |
| Q1 2018 | $2,092,811,000 | +260849.0% | 128,236 | +104.8% | 0.03% | +172.7% |
| Q4 2017 | $802,000 | -45.1% | 62,618 | -47.2% | 0.01% | +22.2% |
| Q3 2017 | $1,460,000 | +46.3% | 118,685 | -0.4% | 0.01% | +28.6% |
| Q2 2017 | $998,000 | -5.5% | 119,176 | +0.9% | 0.01% | 0.0% |
| Q1 2017 | $1,056,000 | +2.0% | 118,155 | +0.3% | 0.01% | 0.0% |
| Q4 2016 | $1,035,000 | +55.4% | 117,751 | +19.3% | 0.01% | +40.0% |
| Q3 2016 | $666,000 | +90.3% | 98,718 | +0.5% | 0.01% | +66.7% |
| Q2 2016 | $350,000 | +20.7% | 98,187 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $290,000 | -29.3% | 98,187 | +1.0% | 0.00% | -33.3% |
| Q4 2015 | $410,000 | -7.7% | 97,260 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $444,000 | -33.6% | 97,260 | +4.9% | 0.00% | -40.0% |
| Q2 2015 | $669,000 | -12.9% | 92,722 | -11.0% | 0.01% | -16.7% |
| Q1 2015 | $768,000 | +61.7% | 104,197 | +3.8% | 0.01% | +100.0% |
| Q4 2014 | $475,000 | +32.7% | 100,391 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $358,000 | +1.4% | 100,391 | +29.7% | 0.00% | +50.0% |
| Q2 2014 | $353,000 | -24.2% | 77,423 | -22.0% | 0.00% | -33.3% |
| Q1 2014 | $466,000 | -6.2% | 99,252 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $497,000 | -19.4% | 99,252 | 0.0% | 0.00% | -40.0% |
| Q3 2013 | $617,000 | +39.0% | 99,252 | +1.6% | 0.01% | +25.0% |
| Q2 2013 | $444,000 | – | 97,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |